Stanley Druckenmiller's position in SpringWorks Therapeutics is currently worth $39.7 Million. That's 1.14% of their equity portfolio (25th largest holding). The investor owns 1.15% of the outstanding SpringWorks Therapeutics stock. The first SpringWorks Therapeutics trade was made in Q2 2024. Since then Stanley Druckenmiller bought shares one more times and sold shares on one occasions. The stake costed the investor $35.4 Million, netting the investor a gain of 12% so far.